Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/amlodipine versus valsartan alone for left ventricular diastolic dysfunction in hypertension
IRCT20201102049232N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hypertension (HTN) comparing Single-pill valsartan + amlodipine with Valsartan alone (2 arms). Primary endpoint: Left ventricular diastolic dysfunction. Started Dec 2020; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT20201102049232N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201102049232N1.